Table 1.
Demographics and clinical characteristics of 302 patients with BSIs due to Candida species considered in this study.
Table 2.
Outcome of 188 elderly patients with BSIs due to Candida species considered in this study.
Table 3.
Outcome of 114 younger patients with BSIs due to Candida species considered in this study.
Fig 1.
30-days survival of older (circle) vs younger (squares) patients with candidemia with septic shock (A) and without any antifungal therapy (B).
Fig 2.
Fluconazole (A), amphotericin B (B), and caspofungin (C) MICs for clinical isolates of Candida spp. recovered from younger (gray bars) and older (black bars) patients.